This article systematically reviews the evidence for a role of glutathione redox in the aetiology of autism spectrum disorders and considers the research questions: 1) Is there an association between metabolites/co-factors/genes/enzymes of the -glutamyl cycle or trans-sulphuration pathway and autism spectrum disorders
Salvador J, Gutierrez G, Llavero M, Gargallo J, Escalada J, Lpez J
In reality, the recommendation to cycle AOD-9604 is not science-based
The real value of the shot is in supporting your livers fat-processing ability, boosting your energy for workouts, and helping your body access stubborn stored fat for fuel
Lauren works with you and is honest with your needs and wants
Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)